Navigation Links
Another Potential Of Stem Cells Discovered: Used For Growing Cartilage

In a breakthrough, scientists have successfully converted human embryonic stem cells into cartilage cells, raising hope that in future, replacement cartilage could be grown for transplantation for a number of injuries and medical // problems, including sports injuries, new cartilage for people having hip replacements, and even for cosmetic and reconstructive surgery.

The research, to be published in the journal Tissue Engineering, involved growing human embryonic stem cells with chondrocytes or cartilage cells, in Petri dishes in the laboratory in a specialized system that encouraged them to change into cartilage cells. When this was compared with just growing the human embryonic stem cells alone, the mixed stem cells and cartilage were found to have higher levels of collagen, the protein constituent of cartilage.

The cells were then implanted in mice on a bioactive scaffold for 35 days. When they removed the scaffold, the cells were found to have formed new cartilage, showing they can be successfully transplanted in living tissue.

When removing head and neck cancers, surgeons often have to cut away parts of cartilage, and then take grafts from other parts of the body. With this new technique doctors would potentially be able to take stem cells from the patient, grow them in a laboratory, and then transplant them after the surgery.

The research, carried out by a team at Imperial College London, builds on an earlier collaboration between medical researchers and engineers at Imperial College. The team had previously developed the bioactive scaffold, which was used as a scaffold to grow the stem cells on.

Dr Archana Vats, first author of the study, said: ‘The ability to grow cartilage using stem cells could have enormous implications for a number of medical problems. Although doctors have been able to carry out joint replacements for a number of years, it has not been possible to replace the worn-out c
'"/>




Page: 1 2

Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Another injectable contraceptive Pill approved by FDA
3. The Possibility Of Fighting HIV with Another Virus Questioned
4. New Research Has Found Another Use For Botox
5. Yet Another Harmful Consequence Of Smoking
6. Another Treatment Option for Benign Tumors
7. Yet Another Treatment Option For Cancer
8. Another Alternative For Diabetics On Insulin
9. Another Use For Epilepsy Drugs
10. Another Cause of Thyroid Cancer Discovered
11. Yet Another Use For Cell Phone Cameras

Post Your Comments:
(Date:11/9/2009)... Tomorrow may be too late ...s condition, according to TOPS Club, Inc. (Take Of...ort organization. , (Vocu...en it comes to preventing or improving a diabetes ...Pounds Sensibly), the nonprofit weight-loss suppor...
(Date:11/9/2009)..., The National Comprehensive Cancer Network (NC...ent that details a draft paradigm for near-term co... upon existing data. The document introduces the N...sensus-based process that compares the risk-versus...d in the NCCN Clinical Practice Guidelines in Onco...
(Date:11/9/2009)..., March of Dimes Names 2010 National Ambassad...USNewswire/ -- Joshua Hoffman of Weston, Fla., was...ans that doctors could not say whether he would su...ar. Today, the 6-year-old was named March of Dimes...lanie Hoffman, recalls, "My first minutes of mothe...
(Date:11/9/2009)..., NEW YORK, Nov. 9 Th...l make its world television debut on the Sundance ...8 p.m. EST/PST. ,, Directed by Academy Award&#...journeys of children with type 1 diabetes amid the...one the world,s poorest countries. The children ar...
(Date:11/9/2009)..., NEW YORK, Nov. 9 /PRNewswire/ -- Phoenix ...nd drug abuse treatment and prevention program, an...., a nationally and internationally recognized lea...Chief Clinical Officer, effective January 1, 2010.... of substance abuse treatment research and her wor...
Breaking Medicine News(10 mins):Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 4Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 6Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3
... strategic fit with highly complementary businesse...pend Management - $12-14 million of expecte...ted to be accretive to earnings per share in 2009,...d National Medical Health Card Systems, Inc. ("NMH...
...k Exchange Symbol: CYT ...ewswire-FirstCall/ - CryoCath(R) Technologies,Inc....at cardiac,arrhythmias, today announced that Chief...hief Financial Officer at,CryoCath. Mr. Lindsay ha...
...ORONTO, Feb. 26 /PRNewswire-FirstCall/ - Bradmer P...dicated to the development and,commercialization o...data,on the Company,s Neuradiab product candidate ...g/cgi/rapidpdf/15228517-2007-053v1 ),This report s...
...nn., Feb. 26 Construction is,underway to expand T...ng,the size of the six-year-old location. When com... exam and procedure rooms, improved privacy for,in...cal staff, including cardiovascular surgery, which...
.... 26 Carriage Services, Inc.,(NYSE: CSV ) today ...,year-end results on Thursday, March 6, 2008 after...e, Carriage Services has scheduled a conference,ca...07 Earnings Conference Call, When: Friday, March...
...cord Revenues of NIS 1.1 Billion With a 14% Rise i...s Merger Paying Off: Q4 Gross Margin of 33% & Rec... (Adjusted), PETACH TIKVA, Israel, February 26 ...ancial results for the fourth quarter and full yea...
Other Medicine News:Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 2Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 3Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 4Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 5Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 6Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 7Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 8Health News:CryoCath Appoints New Chief Financial Officer 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 3Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 4Health News:Expansion Will Double Size of The Heart Center at Regions Hospital 2Health News:Carriage Services Announces Fourth Quarter and Year-End Earnings Release and Conference Call Schedule 2Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 2Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 3Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 4Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 5Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 6Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 7Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 8Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 9Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 10Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 11Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 12
(Date:11/9/2009)...e/ -- Bend Research Inc., a company,with more than...rmaceutical,technologies to help clients solve the...s, announced today that it has entered into a coll..., a global biotechnology company,headquartered in ...ration, Vertex will utilize Bend,s formulation,dev...
(Date:11/9/2009)...- PAREXEL International Corporation (Nasdaq: PRXL...ovider, today announced that it has enhanced its c...l development through an alliance with Mortara Ins...electrocardiogram (ECG) devices and related techno...t,s Surveyor Telemetry Central System to supplemen...
(Date:11/9/2009)...rstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: ...or drug discovery and life sciences research, toda...nd Services (CDAS) unit has been awarded a new fun...t with the Environmental Protection Agency (EPA) f...task order increases the cumulative funding Calipe...
Breaking Medicine Technology:Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5Caliper Awarded New Task Order for EPA ToxCast Program 2Caliper Awarded New Task Order for EPA ToxCast Program 3Micromet Announces Pricing of Public Offering of Common Stock 13287 1Micromet Announces Pricing of Public Offering of Common Stock 13287 2Micromet Announces Pricing of Public Offering of Common Stock 13287 3Micromet Announces Pricing of Public Offering of Common Stock 13287 4North American Spine Society Expresses Concern Over Proposed Federal Health Care Reform Legislation 53218 1North American Spine Society Expresses Concern Over Proposed Federal Health Care Reform Legislation 53218 2Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 1Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 2Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 3
...gned to Determine Statin Effects on Regression of ...inic researchers will,coordinate the first head-to...edications. The trial intends to begin enrollment ...t commonly prescribed drugs and widely,used to tre...e two drugs, atorvastatin (Lipitor) and rosuvastat...
...alif., Jan. 15 Kosan Biosciences,Incorporated (Na...Phase 2,trial of alvespimycin, the company,s secon...2-positive metastatic breast cancer. Alvespimycin ...vity of multiple oncogenes,and cell signaling path...,key signaling pathway in breast cancer. The objec...
Other Medicine Technology:Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins 2Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer 2Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer 3Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer 4
Ralk Hand Drill
DeMartel (Bailey) Wire Saw Guide
Cranial Drill
Cone Skull Punch
Medicine Products: